Delpacibart etedesiran led mostly to mild to moderate adverse events in a phase I/II trial of myotonic dystrophy type 1, but two serious events occurred. The antibody-oligonucleotide conjugate reduced ...

Myotonic dystrophy type 1 is a rare, dominantly inherited, progressive, disabling, neuromuscular disease that leads to decreased life expectancy and has no approved therapies. The disease is caused by ...

ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...

Edited by Michelle H. Teplensky, Boston University, Boston, MA; received July 19, 2024; accepted February 28, 2025 by Editorial Board Member Chad A. Mirkin Identifying clear correlates of protection ...

Conjugated hyperbilirubinemia occurs when bilirubin, a by-product of red blood cells, builds up in the blood. This can indicate several underlying causes, such as hepatitis, cirrhosis, or biliary ...

LOS ANGELES--(BUSINESS WIRE)--Poder Latin, Mundial Media, Conexion and Autonomy Strategies are proud to announce its Nos Ayuda a Vivir campaign is a finalist for two prestigious Reed Awards, Best ...

Researchers have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results, the approach combined the benefits of ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The most successful ...

Abstract: Modeling the relationships that may connect optimal parameter vectors is essential for the performance of parameter estimation methods in distributed networks. In this paper, we consider a ...

aDepartment of Clinical Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen ...